KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads.

Wei-Chou Chang, Hsian-He Hsu, Sung-Hua Chiu, Wen-Yen Huang, Cheng-Hsiang Lo, Hsuan-Hwai Lin, Pei-Ching Huang, Yu-Lueng Shih, Yung-Liang Wan

J Hepatocell Carcinoma 8 937-949

PMID34422707
PMCIDPMC8373306
DOI10.2147/JHC.S319920
发表日期2021-08-23
摘要

摘要

Drug-eluting beads transarterial chemoembolization (DEB-TACE) is an alternative to conventional lipiodol-based TACE (cTACE) to treat hepatocellular carcinoma (HCC). With the advancement in pharmacology, small-caliber DEB-TACE (<100 μm) has been introduced since 2016. For the treatment of hepatic neoplasms or HCC, there is a tendency to use smaller beads by DEB-TACE to achieve more extensive tumor necrosis and a significant reduction in liver toxicity in comparison with that caused by cTACE. However, the indications and potential complications of small-caliber DEB-TACE remain uncertain and have not been well established, due to lack of randomized phase III clinical trials. Instead of systematic or meta-analysis review, this narrative review article describes the suggested indications and contraindications of DEB-TACE with small DEBs, benefit of super-selective embolization of the feeding arteries and the recommended selection of small-caliber DEB. This review was approved by the institutional review board (File Number: 1-105-05-158).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。